PCP Team

PCP enters into financing partnership with Carestone, the market leading German developer of senior living facilities

To strengthen PCP’s presence and capabilities across German-speaking Europe, Natalia Nowak is joining the investment team.

In July 2020, PCP became long-term financing partner with Venandi Livs.

PCP supports ownership transfer of Santa Fe Relocation from Santa Fe Group

Meet our new colleagues

PCP IV provided a commitment for a six-year senior secured USD 60 million loan to Ovzon AB

PCP IV provided a ten-year GBP 25 million subordinated loan to Arbuthnot Banking Group PLC

PCP provided a GBP 25 million term loan to the United Kingdom-based land development group Land Promotions

PCP IV has provided expansion capital to Better Energy, a leading Danish solar energy company

PCP provided a SEK 600m asset backed term loan to the Norwegian real estate company Host Hoteleiendom AS

PCP lent EUR 43m to Monaghan Mushrooms to support the owner, the Wilson family

PCP provided a term loan of GBP 20m to the United Kingdom-based land development company Ampersand Homes

PCP Alpha acquired EUR 11.5 million of Eterna’s, a leading manufacturer of shirts and blouses, senior secured Schuldschein loan

PCP provided expansion capital to the UK and Irish pub and restaurant operator East London Pub Co.

PCP part-financed the UK-based private equity house Elysian Capital’s and management’s acquisition of Key Travel

PCP III has provided a GBP 42 million senior secured facility to UK gym operator Xercise4Less

Ten years after the banking crisis became visible with Lehman Brothers and other bank failures, the market for corporate funding has radically changed

PCP became Technopath Clinical Diagnostics' long-term financing partner by lending growth capital to enhance Technopath Clinical Diagnostics

PCP provided senior secured term loans of over EUR 10 million to the wellyou Group

PCP provided a senior secured term loan of SEK 150 million to Scandector AB

PCP provided a subordinated loan with additional commitments to the German family-owned pharmaceutical company Cheplapharm Arzneimittel GmbH